May 14, 2014 8:26 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
In a report published Wednesday, Stifel analyst Shlomo Rosenbaum initiated coverage on
IMS Health Holdings (NYSE: IMS) with a Buy rating and $29.00 price target.In the report, Stifel noted, “We are initiating coverage of IMS Health Holdings, Inc. (IMS) with a Buy rating on the shares. Our $29 target price assumes the company will achieve about a 5% FCF yield on our 2015 FCF estimates, and is consistent with the average FCF yield of the Business Information Services group on 2014 estimates. This valuation implies about 18.3x 2015 adjusted EPS, roughly similar to the EPS multiples of EFX and NLSN on 2014 numbers – we are assuming current valuation metrics carry forward to 2015.”IMS Health Holdings closed on Tuesday at $25.21.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.